Patients Adherence to Dual Antiplatelet after Percutaneous Coronary Intervention with Drug Eluting Stent Covered by Government Insurance (Sehat Card Plus Program)- An Experience from a Large Tertiary Care Cardiac Center in a Low to Middle Income Country

Abstract

Background: Percutaneous coronary intervention (PCI) is a critical procedure for patients with coronary artery disease. Ensuring adherence to dual antiplatelet therapy (DAPT) post-PCI is essential for optimal patient outcomes. This study explores the impact of DAPT adherence on patient health and mortality rates in a hospital setting. Objective: To investigate the outcomes associated with patient adherence to DAPT following PCI. Methods: This cross-sectional study enrolled 502 PCI patients at the Peshawar Institute of Cardiology from November 2022 to October 2023. All patients were prescribed DAPT and followed up 7 months post-PCI. Data were collected using a pre-designed questionnaire and analyzed with SPSS Version 25. Results: The study enrolled 502 patients with a mean age of 60.19 ± 10.01 years. Among them, 66.5% (334) were male, and 33.5% (168) were female. Adherence to DAPT was 100%, with a mortality rate of 0.2% (1 patient). All patients were educated. The prevalence rates for diabetes mellitus, hypertension, and tobacco use were 19.9% (100 patients), 35.1% (176 patients), and 8.6% (43 patients), respectively. Conclusion: The study concluded that high adherence to DAPT post-PCI is significantly associated with improved patient health and a low mortality rate.